Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risk and benefit evaluation in development of pharmaceutical products

C S Aaron1, P R Harbach, S S Mattano

  • 1Upjohn Company, Kalamazoo, MI 49001.

Environmental Health Perspectives
|October 1, 1993
PubMed
Summary

Genetic heterogeneity in patients complicates new drug safety evaluations. This study examines drug genotoxicity, considering patient genetic variations and specific drug examples to assess potential risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Immunohistochemical expression of p53 with different clonal numbers in gastric adenocarcinoma and its significance].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2022
Same author

[Sensitization characteristics of Juniperus chinensis pollen in Beijing area].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2022
Same author

[Gene expression profile analysis involved in pathogenesis of allergic rhinitis by using bioinformatics method as a novel way of drug screening].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2018
Same author

[Observation on pollinosis with vegetable food allergy].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2018
Same author

[Clinical observation on specific immunotherapy of allergic rhinitis with artemisia pollen].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2018
Same author

Veterinary and human biobanking practices: enhancing molecular sample integrity.

Veterinary pathology·2013

Area of Science:

  • Pharmacology and Toxicology
  • Genetics and Genomics
  • Drug Safety Evaluation

Background:

  • Patient genetic heterogeneity impacts drug metabolism and repair capacity, complicating safety assessments.
  • Evaluating drug safety requires assessing multiple parameters due to biological activity and potential off-target effects.
  • Genotoxicity testing is crucial for understanding potential risks associated with pharmaceutical products.

Purpose of the Study:

  • To explore the complexities of new drug safety evaluation in genetically diverse patient populations.
  • To address recurrent genotoxicity questions, such as the relevance of in vitro chromosomal aberration induction.
  • To discuss specific examples of risk assessments for pharmaceutical compounds.

Main Methods:

  • Review of safety evaluation data for pharmaceutical products.

Related Experiment Videos

  • Analysis of genotoxicity assays, including in vitro chromosomal aberration tests.
  • Case studies of specific drugs (U-48753E, U-54461, U-68,553B) to illustrate risk assessment challenges.

    • Main Results:

    • Drug U-48753E showed slight mutagenicity in the AS52 assay, prompting investigation into its metabolism.
    • Drug U-54461 demonstrated in vitro chromosome-breaking ability, but in vivo data significantly reduced safety concerns.
    • The relevance of in vitro genotoxicity findings at high doses and sampling times remains a key consideration.

    Conclusions:

    • Genetic heterogeneity is a critical factor in pharmaceutical safety evaluation.
    • Comprehensive risk assessment requires integrating in vitro and in vivo data.
    • Careful evaluation of genotoxicity is essential for ensuring patient safety.